Iradimed
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $18,325 | $17,928 | $17,598 | $17,452 |
Gross Profit | 14,191 | 14,009 | 13,387 | 13,412 |
EBITDA | 5,789 | 5,627 | 5,469 | 5,887 |
EBIT | 5,789 | 5,427 | 5,243 | 5,681 |
Net Income | 5,049 | 4,901 | 4,136 | 4,539 |
Net Change In Cash | 18,325 | 17,928 | 17,598 | 17,452 |
Free Cash Flow | 5,104 | 5,368 | 3,404 | 3,279 |
Cash | 51,721 | 48,535 | 45,126 | 49,762 |
Basic Shares | 12,778 | 12,757 | 12,749 | 12,739 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $65,562 | $53,303 | $41,814 | $31,717 |
Gross Profit | 50,158 | 41,282 | 32,049 | 23,574 |
EBITDA | 20,035 | 16,298 | 11,224 | 582 |
EBIT | 20,035 | 15,627 | 10,590 | -20 |
Net Income | 17,192 | 12,827 | 9,325 | 1,369 |
Net Change In Cash | 65,562 | 53,303 | 41,814 | 31,717 |
Cost of Revenue | -4,038 | 11,930 | 6,586 | |
Free Cash Flow | 5,457 | 8,167 | 10,516 | 5,180 |
Cash | 49,762 | 57,960 | 61,999 | 50,068 |
Basic Shares | 12,722 | 12,635 | 12,590 | 12,440 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $0.43 |
2024-06-30 | $0.42 |
2024-03-31 | $0.36 |
2023-12-31 | $0.39 |
